A Multicenter, Double Blind, Randomized,Controlled Study of M7824 with Concurrent Chemoradiation Followed by M7824 versus Concurrent Chemoradiation Plus Placebo Followed by Durvalumab in Participants with Unresectable Stage III Non-small Cell Lung Cancer

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Scope

National

Locations

Greeley Campus
Harmony Campus
Medical Center of the Rockies
Poudre Valley Hospital

Study ID

Protocol Number: 19-6065

More information available at ClinicalTrials.gov: NCT03840902

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers